The 12-module Foundations Course in Cannabinoid Therapy is USD $500. Individual 40-minute modules with a quiz are USD $100 when available; unfinished modules are open for registration of interest only. A certificate of completion is provided on completion of a course or module.
These completed courses and modules are available now, with access beginning after confirmed payment.
The plant, major product types and lawful clinical contexts, with clear distinctions between historical use, biological plausibility and modern clinical evidence.
A widely distributed signalling system involved in the regulation of numerous physiological processes, providing important biological context for understanding the actions of cannabinoids.
Cannabinoid mechanisms and clinical research in anxiety, including limited or mixed evidence, formulation-specific findings and important safety cautions.
Preclinical cannabinoid research in brain cancer, the limited state of clinical evidence, and separate consideration of symptom and supportive-care research.
Laboratory and preclinical cannabinoid research in cancer, the current limits of clinical evidence, and the distinction between anticancer claims and symptom or supportive-care considerations.
A condition- and product-specific appraisal of clinical evidence across selected neurological disorders, including areas where findings are limited, mixed or absent.
Endocannabinoid mechanisms, observational associations and the limited clinical evidence concerning medicinal cannabis in diabetes and metabolic health.
Regulator-approved cannabidiol uses in specific epilepsy syndromes, relevant controlled trials, and the limits of generalising those findings to other products or seizure disorders.
Endocannabinoid signalling in the gut, mechanistic and preclinical findings, and the current state of clinical evidence for cannabinoid products across selected gastrointestinal indications.
CBG, CBC, CBN and cannabis terpenes, separating laboratory and preclinical findings from clinical evidence and critically examining the entourage hypothesis.
Emerging laboratory and preclinical research into the antimicrobial activity of cannabinoids, the limitations of the current evidence, and questions relevant to possible future clinical translation.
Multi-module courses first, followed by remaining individual modules. Unfinished modules cannot be purchased — register your interest to be notified when they become available. Listed alphabetically within each availability group.
A developing course examining endocannabinoid biology and cannabinoid research across reproductive and women's health, with evidence graded by product, formulation, population and indication.
The Institute's flagship 12-module course in cannabinoid science, safety, evidence appraisal, clinical contexts and prescribing principles. The final three case-study modules are in development, with content being finalised.
An appraisal of controlled trials, observational findings and limitations across particular cannabinoid products, formulations and chronic pain populations.
Absorption, distribution, metabolism and elimination of cannabinoids, together with adverse effects, contraindications and drug–drug interaction considerations.
Sleep architecture and sleep disorders, with critical review of controlled, observational and insufficient evidence for specific cannabinoid formulations.
CBD pharmacology and safety, with appraisal of regulator-approved uses, controlled clinical trials and indications where evidence remains limited or inconsistent.
Case-study content is being finalised. No cases, educators or sponsors are announced at this stage.
Case-study content is being finalised. No cases, educators or sponsors are announced at this stage.
Case-study content is being finalised. No cases, educators or sponsors are announced at this stage.
A review of inhaled cannabinoid delivery, pharmacokinetic differences, device considerations, potential harms and risk-reduction principles.
Principles of patient assessment, product and formulation considerations, titration, monitoring and review within authorised professional scope and local law.